nanodrop

The Food and Drug Administration is seeking to acquire a REVOLVE R4 microscope to enhance the imaging capabilities of the Kemaladewi Laboratory within the Gene Therapy Immunology Branch. This versatile instrument supports both upright and inverted imaging, facilitating brightfield and multi-channel fluorescence imaging for the characterization and evaluation of gene therapy products. By integrating these functions into a single device, the agency aims to reduce the necessity for multiple microscopes. This acquisition will replace an existing brightfield-only microscope, significantly expanding the laboratory's technical capacity to support critical research and regulatory science activities. The procurement is categorized under NAICS code 334516 and is currently listed as a forecast. Coordination for this requirement is managed through the CBER Acquisition Liaison.